Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 33 min ago
Peer-reviewedCC BY 4.0JMIR Pediatrics and Parenting

Parent Anxiety and Response to a Telehealth Intervention for Hypoglycemia Fear: Secondary Analysis of a Randomized Trial

5 affiliations
  1. 1Center for Healthcare Delivery Science, Nemours Children's Clinic, 807 Children's Way, Jacksonville, FL, 32207, United States, 1 904-697-3595, 1 904-697-3425
  2. 2Center for Healthcare Delivery Science, Nemours Children's Clinic, Orlando, FL, United States
  3. 3Division of Psychology, Nemours Children's Clinic, Jacksonville, FL, United States
  4. 4Division of Endocrinology, Children's Mercy Hospital, Kansas City, MO, United States
  5. 5Center for Diabetes Technology, University of Virginia, Charlottesville, VA, United States

Abstract

Background: Parents of young children with type 1 diabetes (T1D) frequently report fear of hypoglycemia (FH), which can impact their diabetes management. REDCHiP (Reducing Emotional Distress for Childhood Hypoglycemia in Parents) is a telehealth-delivered cognitive behavioral intervention shown to reduce FH, but less is known about which parents benefit most.

Objective: This secondary analysis examined whether pretreatment parent anxiety moderated REDCHiP’s effects and explored responder patterns by intervention arm and pretreatment anxiety.

Methods: This was a secondary analysis of a large, randomized clinical trial comparing REDCHiP to an attention control condition (ATTN). We assessed outcomes before treatment (time 1) and 3 months after treatment (time 3). Our primary outcome was parental FH at time 3, adjusted for time 1 FH. The original trial used validated measures of parent FH and general anxiety. We evaluated parent anxiety at time 1 as both a categorical variable (clinically elevated or not) and a continuous variable (centered). We defined responders as parents achieving a reduction of ≥0.5 SDs in FH from time 1 to time 3. An analysis of covariance tested the treatment arm by anxiety interaction, with sensitivity analyses modeling anxiety continuously.

Results: There was no significant treatment arm by anxiety interaction when modeling parent anxiety as either a categorical or continuous variable (P>.05). However, exploratory analyses found that the adjusted mean time 3 FH was numerically lower among REDCHiP parents than ATTN parents with clinically elevated anxiety. Among parents with elevated anxiety, 78.6% (22/28) of REDCHiP parents met our responder criterion compared with 47.4% (9/19) of ATTN parents. Among parents with elevated anxiety, the adjusted odds of meeting the responder criterion were higher for REDCHiP than ATTN parents (odds ratio 6.35, 95% CI 1.47‐29.00).

Conclusions: While time 1 parent anxiety did not significantly moderate treatment response, exploratory analyses suggested a potentially meaningful pattern among parents with clinically elevated anxiety. As telehealth-delivered behavioral interventions expand in pediatric type 1 diabetes care, secondary analyses of participant characteristics may help guide targeted implementation and enhance treatment benefit.

Related

  1. Blood Biomarkers of Alzheimer's Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial
    A. Rosenberg, A. Solomon, A. Matton +13
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  2. Participant Characteristics Associated With Loneliness Reduction During a Digital Social Robot Intervention Among Older Adults Living Alone in Japan: Secondary Analysis of a Randomized Controlled Trial
    Hiroshi Murayama, Mai Takase
    Journal of Medical Internet ResearchPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  3. Efficacy of a personalized, response-based transdiagnostic intervention for emotional disorders delivered via the Internet: a protocol for an adaptive randomized controlled trial
    Fernanda Longo Elia, Azucena García-Palacios, Cristina Botella +4
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
  4. Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome
    Manabu Saito, Hiroshi Uchino, Arisa Yoshida +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. The Moderating Effects of Race and Ethnicity on a Motivational Interviewing Intervention for Improving Physical Health Among Patients With Peripheral Artery Disease: Secondary Analysis of a Pilot Randomized Trial
    Yiliang Zhu, Tracie Collins
    JMIR Formative ResearchPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
BibTeX
@article{patton2026parent,
  title = {{Parent Anxiety and Response to a Telehealth Intervention for Hypoglycemia Fear: Secondary Analysis of a Randomized Trial}},
  author = {Susana R Patton and Alexandra Monzon and Nicole Kahhan and Jacob Redel and Kimberly Driscoll},
  journal = {JMIR Pediatrics and Parenting},
  year = {2026},
  month = nov,
  doi = {10.2196/95475},
  url = {https://doi.org/10.2196/95475},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Parent Anxiety and Response to a Telehealth Intervention for Hypoglycemia Fear: Secondary Analysis of a Randomized Trial
AU  - Susana R Patton
AU  - Alexandra Monzon
AU  - Nicole Kahhan
AU  - Jacob Redel
AU  - Kimberly Driscoll
PY  - 2026
DA  - 2026/11/03
JO  - JMIR Pediatrics and Parenting
DO  - 10.2196/95475
UR  - https://doi.org/10.2196/95475
AB  - Background: Parents of young children with type 1 diabetes (T1D) frequently report fear of hypoglycemia (FH), which can impact their diabetes management. REDCHiP (Reducing Emotional Distress for Childhood Hypoglycemia in Parents) is a telehealth-delivered cognitive behavioral intervention shown to reduce FH, but less is known about which parents benefit most.  Objective: This secondary analysis examined whether pretreatment parent anxiety moderated REDCHiP’s effects and explored responder patterns by intervention arm and pretreatment anxiety.  Methods: This was a secondary analysis of a large, randomized clinical trial comparing REDCHiP to an attention control condition (ATTN). We assessed outcomes before treatment (time 1) and 3 months after treatment (time 3). Our primary outcome was parental FH at time 3, adjusted for time 1 FH. The original trial used validated measures of parent FH and general anxiety. We evaluated parent anxiety at time 1 as both a categorical variable (clinically elevated or not) and a continuous variable (centered). We defined responders as parents achieving a reduction of ≥0.5 SDs in FH from time 1 to time 3. An analysis of covariance tested the treatment arm by anxiety interaction, with sensitivity analyses modeling anxiety continuously.  Results: There was no significant treatment arm by anxiety interaction when modeling parent anxiety as either a categorical or continuous variable (P>.05). However, exploratory analyses found that the adjusted mean time 3 FH was numerically lower among REDCHiP parents than ATTN parents with clinically elevated anxiety. Among parents with elevated anxiety, 78.6% (22/28) of REDCHiP parents met our responder criterion compared with 47.4% (9/19) of ATTN parents. Among parents with elevated anxiety, the adjusted odds of meeting the responder criterion were higher for REDCHiP than ATTN parents (odds ratio 6.35, 95% CI 1.47‐29.00).  Conclusions: While time 1 parent anxiety did not significantly moderate treatment response, exploratory analyses suggested a potentially meaningful pattern among parents with clinically elevated anxiety. As telehealth-delivered behavioral interventions expand in pediatric type 1 diabetes care, secondary analyses of participant characteristics may help guide targeted implementation and enhance treatment benefit.
SN  - 2561-6722
ER  -